Wolfram Jung
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 16
- Oncology 15
- CAR-T cell therapy research 8
- Viral-associated cancers and disorders 4
- Co-authors
- Michael Pfreundschuh (11 shared papers)Christoph Renner (9 shared papers)Ulrich Dührsen (2 shared papers)Volker Diehl (5 shared papers)Bernd Metzner (3 shared papers)Hermann Einsele (3 shared papers)Hannes Wandt (2 shared papers)Norma Peter (1 shared paper)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (3 papers)International Journal of Cancer (3 papers)Hematological Oncology (2 papers)Scandinavian Journal of Immunology (2 papers)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Wolfram Jung
39 papers receiving 1.7k citations
Wolfram Jung's Hit Papers
Peers
Comparison fields: 5 of 78
- Pathology and Forensic Medicine 794
- Genetics 333
- Oncology 701
- Hematology 241
- Immunology 457
Countries citing papers authored by Wolfram Jung
This map shows the geographic impact of Wolfram Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfram Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfram Jung more than expected).
Fields of papers citing papers by Wolfram Jung
This network shows the impact of papers produced by Wolfram Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfram Jung. The network helps show where Wolfram Jung may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolfram Jung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma Hit paper breakdown → | 2007 | 632 |
| 2 | 2003 | 214 | |
| 3 | 1994 | 131 | |
| 4 | 1997 | 119 | |
| 5 | Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease. | 1990 | 79 |
| 6 | 1993 | 73 | |
| 7 | 2016 | 53 | |
| 8 | 1995 | 39 | |
| 9 | 2012 | 33 | |
| 10 | 2018 | 32 | |
| 11 | 1991 | 28 | |
| 12 | 1993 | 28 | |
| 13 | 1993 | 28 | |
| 14 | 2006 | 23 | |
| 15 | 1998 | 23 | |
| 16 | 2000 | 17 | |
| 17 | 2006 | 17 | |
| 18 | 2018 | 17 | |
| 19 | 2002 | 15 | |
| 20 | 1992 | 14 |
About Wolfram Jung
Wolfram Jung is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 42 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (16 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), CAR-T cell therapy research (8 papers), T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (6 papers), Viral-associated cancers and disorders (4 papers), Acute Myeloid Leukemia Research (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (794 citations), Genetics (333 citations), Oncology (701 citations), Hematology (241 citations) and Immunology (457 citations). Wolfram Jung has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Michael Pfreundschuh, Christoph Renner, Ulrich Dührsen, Volker Diehl, Bernd Metzner, Hermann Einsele, Hannes Wandt, Norma Peter, Eva Hoster and Hanneke C. Kluin‐Nelemans. Their work appears in journals such as Blood, Journal of Clinical Oncology, International Journal of Cancer, Hematological Oncology and Scandinavian Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.